Skip to main content

Seth Goldblum, James Schoeneck

Premium
BrainCells this week announced the addition of Seth Goldblum as vice president of business development. Goldblum is responsible for evaluating in-licensing and collaboration opportunities for compounds that promote neurogenesis for central nervous system indications. Goldblum reports to CEO James Schoeneck.
 
Prior to joining BCI, Goldblum was head of business development for Senomyx. Before that, he served in executive positions with Vical.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.